Quaker Wealth Management’s Amgen AMGN Stock Holding History

Quaker Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-120	Closed	-$37.4K	–	910
2025 Q1	$37.4K	Buy	+120	New	+$35.4K	0.01%	183

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Quaker Wealth Management's AMGN Position: Q1 2026 in Review

Quaker Wealth Management increased its Amgen (AMGN) stake by 1.7% in Q1 2026, buying an estimated $713 and bringing the position to 122 shares worth $42.9K. The position accounts for 0.01% of the portfolio, ranked #178.

Quaker Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Quaker Wealth Management held 122 shares of Amgen worth $42.9K as of Q1 2026.
Quaker Wealth Management bought 2 Amgen shares in Q1 2026, an estimated $713.
Amgen made up 0.01% of Quaker Wealth Management's portfolio in Q1 2026, its #178 holding.
Quaker Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Quaker Wealth Management's 13F filing for Q1 2026, filed 10 Apr 2026.